If you are exploring peptide therapy, work with a qualified clinician who can help you build a plan that matches your physiology and goals
HHF was significantly reduced by tirzepatide ( n = 2 RCTs), whereas semaglutide ( n = 4 RCTs) showed a non-significant trend toward a reduction
In a randomized, phase 3, open-label trial comparing two oral GLP-1 receptor agonists, a greater percentage of adults receiving orforglipron 12 mg or 36 mg (Eli Lilly) were able to achieve an HbA1c of less than 7%, 6.5% and 5.7% vs
This mental fortitude is crucial when making long-term lifestyle changes, whether youre meal planning, resisting cravings, or pushing through a tough workout
However, the intervention period in the present study was relatively short
CrossRef Liver disease trends in the Asia-Pacific region for the next 50 years Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim Clinical and Molecular Hepatology .2025